Isracann Biosciences (XCNQ:IPOT) EV-to-FCF : -1.66 (As of Apr. 28, 2025)

Isracann Biosciences EV-to-FCF Chart

Isracann Biosciences Annual Data
	Trend	May13	May14	May15	May16	May17	May18	May19	May20	May21	May22
EV-to-FCF		Get a 7-Day Free Trial					-9.98	-3.30	-4.38	-7.11	-6.19

Isracann Biosciences Quarterly Data
	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22
EV-to-FCF	Get a 7-Day Free Trial															-3.49	-3.05	-5.41	-6.19	-4.28

Competitive Comparison of Isracann Biosciences's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Isracann Biosciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Isracann Biosciences's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Isracann Biosciences's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Isracann Biosciences's EV-to-FCF falls into.

Isracann Biosciences EV-to-FCF Calculation

Isracann Biosciences's EV-to-FCF for today is calculated as:

Isracann Biosciences's current Enterprise Value is C$2.44 Mil.
Isracann Biosciences's Free Cash Flow for the trailing twelve months (TTM) ended in Aug. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Isracann Biosciences  (XCNQ:IPOT) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Isracann Biosciences's PE Ratio (TTM) for today is calculated as:

Isracann Biosciences's share price for today is C$0.015.
Isracann Biosciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.036.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Isracann Biosciences EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Isracann Biosciences's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Isracann Biosciences Business Description